Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

March 31, 2003

Conditions
DepressionSchizophreniaSchizoaffective Disorder
Interventions
DRUG

olanzapine

DRUG

ziprasidone

Trial Locations (30)

Unknown

Tuscaloosa

Little Rock

Anaheim

Chula Vista

Lafayette

Long Beach

Orange

Poway

Rosemeade

San Diego

Denver

New Britain

Winter Park

Augusta

Prairie Village

Gaithersburg

Mount Pleasant

St Louis

Lincoln

Clementon

Buffalo

New York

Staten Island

Charlotte

Philadelphia

Sioux Falls

Austin

El Paso

Houston

Salt Lake City

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00034801 - Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter